Study of Remdesivir Drug as Treatment against Coronavirus (COVID-19)
Scientific Research Journal of Pharmacy · 2023
DOI: 10.47310/srjp.2023.v03i02.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Research Journal of Pharmacy, 2023. Verfasst von Abeer Hamoodi Jabbar und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Many scientists searched for an effective treatment for this harmful disease after the recent challenges of the spreading epidemic of coronavirus that invaded many countries and claimed the lives of many people. They tested many drugs, including a drug called Remdesivir, which proved effective against corona patients in a number of countries that used it. In this study, we'll review the information on a drug's composition and side effects when used by patients with the coronavirus in America and Japan. Two days after the National Institutes of Health presented their clinical experience and findings—a huge step forward in the fight against the Corona virus—the Food and Drug Administration issued an emergency statement regarding remdesivir. The FDA's statement was posted in full on its website: Assume that Remdesivir is thought to be potentially successful in treating COVID-19 and that, in the absence of suitable or approved alternatives, treating this potentially fatal or deadly virus outweighs the dangers and risks associated with administering the medication
Zitieren
APA
Jabbar, A. H., Al-Shafai, H. H., Jabbar, M. H., & Kadhim, M. I. (2023). Study of Remdesivir Drug as Treatment against Coronavirus (COVID-19). Scientific Research Journal of Pharmacy. https://doi.org/10.47310/srjp.2023.v03i02.001
Vancouver
Jabbar AH, Al-Shafai HH, Jabbar MH, Kadhim MI. Study of Remdesivir Drug as Treatment against Coronavirus (COVID-19). Scientific Research Journal of Pharmacy. 2023. doi:10.47310/srjp.2023.v03i02.001
BibTeX
@article{Jabbar2023,
author = {Jabbar, Abeer Hamoodi and Al-Shafai, Hussein H. and Jabbar, Mustafa Hamoodi and Kadhim, Muqdad Irhaeem},
title = {Study of Remdesivir Drug as Treatment against Coronavirus (COVID-19)},
journal = {Scientific Research Journal of Pharmacy},
year = {2023},
doi = {10.47310/srjp.2023.v03i02.001}
}
EUVIMED